
Back to index
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
Life Science Leader
Data Management and Information Technology—Do the Benefits Outweigh the Risks?
Life Science Leader
Advancing Sponsor/CRO Collaborations to Improve Preclinical Throughput
Life Science Leader
Not A Popularity Contest
PharmPro
Outsourcing Clinical Research: Established vs. Emerging Markets
April 2012
March 2012
February 2012
January 2012
December 2011
Pharma iQ
Overcoming Barriers to Forming Successful Relationships with CMOs in Emerging Markets
PharmPro
Who should be doing your Pharmaceutical Analytical Testing – a CRO or CMO?
Pharmaceutical Manufacturing
Rating Pharma Contract Manufacturers: Does Perception Equal Reality?
BioSpace
Nice Insight Announces Publication of Its Q4 CRO/CMO Quarterly Intelligence Report
November 2011
October 2011
Life Science Leader
Will A Focus On Innovation Pay Off For Custom Synthesis Providers?
FiercePharma Manufacturing
Top 10 Standout CMOs
BioPharm International
Contract Services Spending: Who's Spending What, and Where?
Pharmaceutical Outsouring
How Relevant are 483s in Terms of Compliance Perception?
SFGate, PRWeb
Therapure Biopharma Inc. wins The CMO Leadership Award
Life Science Leader
Social Media Leads To Editorial – And More
PharmPro
Sterile Manufacturing Oppportunities
Life Science Leader — CMO Leadership Awards supplement issue
It’s About the Customer
PharmaChem
Where do strategic business opportunities lie for mid-tier CROs?
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
NI Company News
NI Published Articles
NI Calendar of Events
NI Media Partners
Contact Us
October 22-24 Messe Frankfurt, Germany
|
|
|
Life Science Leader
September 2012
Written By
Kate Hammeke Director of Marketing Intelligence Nice Insight ![]() ![]() ![]() ![]() ![]()
|
Since its inception, the primary goal of Nice Insight’s Pharmaceutical and Biotechnology Outsourcing Survey has been to optimize collaborations between CROs/CMOs and sponsor organizations. The benefits of improved collaborations play out in many forms, and offer advantages every step of the way—from reduced costs, improved staff efficiencies and increased shareholder value all the way to more affordable medicines for consumers. Outsourcing Insights has been a platform for Nice Insight to share some simple strategies on how to get the best results from an outsourcing relationship, whether that relationship is tactical, with a preferred vendor or strategic partnership. Each of these different types outsourcing relationships has its merits, and, not surprisingly, most sponsor organizations engage CROs that fall into each category—only 5% of respondents stated all of the CROs they work with are strategic partners.
The results from a recent strategic partnering survey indicated that approximately one-third of total outsourcing expenditure on early stage development is spent with each type of CRO alliance. This is both interesting and important because for the past several years, the talk of the industry has been directed primarily at a “strategic partnership model.” So much so, that the investment firm Morningstar has reported that “this type of partnership model has been key to CRO success and growth” (referring to an 11.1% increase in CRO revenue in 2011). However, if a CRO focuses solely on engaging in strategic partnership modeled relationships, the company may be inadvertently missing out on the bulk of sponsors’ financial outlay. Overall, sponsors indicated they spend more than two-thirds of their expenditure with tactical providers (37%) and preferred vendors (34%). As a contract service provider, the key is to know when to position the business as each type of provider, and how to win business slated for each provider category. Similar to building an investment portfolio that will maximize profits while limiting risks, diversity is essential. Diversity in outsourcing alliances—from both the sponsor side and the contractor side—protects each party from the old cliché of putting all of ones eggs in a single basket and enables tiered benefits from the different relationships. For the same reason a financial advisor should steer an investor away from putting all of her money into one type stock, it’s not a good idea to put all business development efforts into forming strategic partnerships. Likewise, from a sponsor prospective, there will be times when the benefit of engaging a CRO on a tactical level outweighs the benefit of using a preferred provider or strategic partner for the same job. |
|
|
| Each time Nice Insight has asked the sponsor audience about their interest in forming strategic partnerships (defined as a long-term, win-win commitment that maximizes the effectiveness of both participants resources), the results come out in strong favor—fewer than 10% of respondents were neutral or uninterested. However, when these same respondents move on to a series of questions that help to establish their rationale behind outsourcing, the results frequently point towards tactical motivations. This is a fundamental challenge to the strategic partnership model because the reasoning used by these decision makers doesn’t always contribute to the results they say they want. Affirming an interest in strategic partnerships, yet placing a heavy emphasis on “process” over “outcome” or “access to capacity” over “access to best in class performance” speaks to the complexity of outsourcing motivations. The graph on the following page shows the characteristics respondents selected that best coincide with their business’s operating model when working with outsourcing partners. Understanding and applying this information will help CROs to refine their approach by speaking to the underlying factors that prompted the sponsor to outsource the services. It may also help sponsors better understand their own outsourcing motivations, and identify opportunities to maximize the benefits of outsourcing to a diverse assortment of CROs. | |






















